JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MNTX
5551
DELISTED
Manitex International, Inc.
MNTX
| $57.5K | ﹤0.01% |
12,988
-21,511
| -62% | -$125K |
2023 Q4
2 quarters
|
|
5552
CALL
ARK Innovation ETF
ARKK
$9.57B
| $57.1K | ﹤0.01% |
+1,300
| New | +$58.1K |
2024 Q2
0 quarters
|
|
5553
PUT
International Flavors & Fragrances
IFF
$21.2B
| $57.1K | ﹤0.01% |
+600
| New | +$55K |
2024 Q2
0 quarters
|
|
|
ZTEK
5554
DELISTED
Zentek
ZTEK
| $56.8K | ﹤0.01% |
20,000
| – | – |
2023 Q3
3 quarters
|
|
5555
Brookstone Intermediate Bond ETF
BAMB
$54.9M
| $56.7K | ﹤0.01% |
+2,208
| New | +$56.5K |
2024 Q2
0 quarters
|
|
5556
Eastern Company
EML
$145M
| $56.5K | ﹤0.01% |
2,220
-2,395
| -52% | -$69.8K |
2017 Q4
26 quarters
|
|
|
LKFT
5557
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
| $56.5K | ﹤0.01% |
2,281
-2,120
| -48% | -$60.2K |
2019 Q1
21 quarters
|
|
|
EVA
5558
DELISTED
Enviva Inc.
EVA
| $56.4K | ﹤0.01% |
131,138
| – | – |
2018 Q2
24 quarters
|
|
5559
Davis Select US Equity ETF
DUSA
$1.23B
| $56.3K | ﹤0.01% |
1,385
+655
| +90% | +$26K |
2023 Q4
2 quarters
|
|
5560
Entravision Communication
EVC
$681M
| $56K | ﹤0.01% |
27,611
+2,607
| +10% | +$5.4K |
2017 Q1
29 quarters
|
|
5561
Invesco Large Cap Growth ETF
PWB
$2.67B
| $55.9K | ﹤0.01% |
592
| – | – |
2016 Q1
33 quarters
|
|
|
SCPH
5562
DELISTED
scPharmaceuticals
SCPH
| $55.6K | ﹤0.01% |
12,786
+777
| +6% | +$3.41K |
2022 Q4
6 quarters
|
|
5563
Invesco Financial Preferred ETF
PGF
$616M
| $55.5K | ﹤0.01% |
3,766
+3,645
| +3,012% | +$53.8K |
2014 Q1
41 quarters
|
|
5564
Pearson
PSO
$9.71B
| $55.4K | ﹤0.01% |
4,437
+579
| +15% | +$7.13K |
2014 Q3
39 quarters
|
|
5565
Fidelity Low Duration Bond Factor ETF
FLDR
$2.32B
| $55.2K | ﹤0.01% |
1,105
+444
| +67% | +$22.2K |
2023 Q3
3 quarters
|
|
5566
Opus Small Cap Value ETF
OSCV
$623M
| $55.1K | ﹤0.01% |
1,597
| – | – |
2022 Q4
6 quarters
|
|
5567
WisdomTree International Multifactor Fund
DWMF
$32.8M
| $54.9K | ﹤0.01% |
2,099
-3,752
| -64% | -$99.5K |
2022 Q4
6 quarters
|
|
5568
Innovator US Equity Accelerated 9 Buffer ETF April
XBAP
$128M
| $54.8K | ﹤0.01% |
+1,698
| New | +$53.3K |
2024 Q2
0 quarters
|
|
5569
908 Devices
MASS
$517M
| $54.8K | ﹤0.01% |
10,633
+1,412
| +15% | +$8.53K |
2021 Q1
13 quarters
|
|
5570
Latham Group
SWIM
$738M
| $54.7K | ﹤0.01% |
18,048
-9,436
| -34% | -$32.9K |
2021 Q2
12 quarters
|
|
5571
CALL
Fulcrum Therapeutics
FULC
$281M
| $54.6K | ﹤0.01% |
+8,800
| New | +$66.7K |
2024 Q2
0 quarters
|
|
5572
Solid Biosciences
SLDB
$748M
| $54.6K | ﹤0.01% |
9,622
-60,655
| -86% | -$543K |
2018 Q1
25 quarters
|
|
5573
Nerdy
NRDY
$69.4M
| $54.4K | ﹤0.01% |
2,173
-1,626
| -43% | -$53.6K |
2021 Q2
12 quarters
|
|
5574
Perma-Fix Environmental Services
PESI
$327M
| $54.3K | ﹤0.01% |
5,361
+4,618
| +622% | +$51.2K |
2023 Q4
2 quarters
|
|
5575
CALL
Cytokinetics
CYTK
$9.12B
| $54.2K | ﹤0.01% |
1,000
-35,000
| -97% | -$2.11M |
2023 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.